Clinical trial
A Prospective, Multicenter, Single-Arm Clinical Study Evaluating the Safety and Effectiveness of The Tixel Fractional System in The Treatment of Periorbital Wrinkles
NCT04639713 is registered in ClinicalTrials.gov with Novoxel Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single-Arm Clinical Study Evaluating the Safety and Effectiveness of The Tixel Fractional System in The Treatment of Periorbital Wrinkles
- Lead sponsor
- Novoxel Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 2, 2021
- Completion date
- April 4, 2022
- Enrollment
- 51 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
fractional, periorbital, resurfacing, tixel 2, wrinkle